Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034931792> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2034931792 abstract "The human epidermal growth factor receptor subunit (HER2), or ErbB2, is receptor tyrosine kinase that is amplified in approximately 20-25% of invasive breast cancers. Anti-HER2 therapies such as trastuzumab (Herceptin®) have become important in the management of aggressive and metastatic breast cancer. Although many patients with HER2-positive breast cancer initially respond to anti-HER2 treatments, such as trastuzumab, a significant portion of them develop resistance to these therapies. Consequently, there is a great need to develop therapies that will treat these tumors once they become resistant. We have developed a unique drug delivery protein (HerPBK10) that specifically targets the cell surface receptor HER3, which has been shown to be elevated in trastuzumab-resistant HER2+ breast cancers. HerPBK10, once it has bound to the HER3 receptor subunit, triggers rapid endocytosis and endosomal penetration, enabling it to deliver a toxic payload to the cell, resulting in cell death. We hypothesized that cytotoxic drugs delivered by HerPBK10 would induce significant targeted cell death in trastuzumab-resistant Her2+ breast cancers and will provide an effective treatment for patients who have developed these resistant tumors. We have demonstrated that HerPBK10 binds specifically to HER3 in vitro and binds to the cell surface of three different breast cancer cell lines. Importantly, this binding can be competitively inhibited by free HER3 ligand, indicating that HerPBK10 binds specifically to HER3. We also examined whether cells that have become resistant to trastuzumab have altered levels of HER receptors on their surface when compared to parental, trastuzumab-responsive, cancer cells. We demonstrated in multiple trastuzumab-resistant cell lines that HER3 receptor levels are significantly increased. We then assembled HerPBK10 with a cytotoxic gallium corrole, which we have previously demonstrated to be toxic once taken up into a cell. The resulting nanoparticle, called HerGa, was used to treat three different aggressive breast cancer cell lines (one that is susceptible to trastuzumab treatment and two that have become resistant to trastuzumab) and demonstrated that HerGa caused cell death in all three cell lines, but at a greater level and at a lower dosage in the resistant cell lines. We also compared the effect of the HerGa nanoparticle to trastuzumab and showed that it caused greater overall cell death. Together, these results indicate that our HER3-targeting nanoparticle, HerGa, efficiently targets and kills cancer cells that have become resistant to trastuzumab, and warrants further in vivo testing to investigate its potential as a treatment for patients who have become non-responsive to traditional anti-HER2 therapies. Citation Format: Jessica D. Sims, Michael Taguaim, Chris Hanson, Xiaojiang Cui, Lali K. Medina-Kauwe. Treating trastuzumab-resistant HER2+ breast cancers with a HER3-targeted nanoparticle. [abstract]. In: Proceedings of the AACR Special Conference on Tumor Invasion and Metastasis; Jan 20-23, 2013; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2013;73(3 Suppl):Abstract nr A101." @default.
- W2034931792 created "2016-06-24" @default.
- W2034931792 creator A5026474600 @default.
- W2034931792 creator A5034898797 @default.
- W2034931792 creator A5047542675 @default.
- W2034931792 creator A5062083547 @default.
- W2034931792 creator A5077883471 @default.
- W2034931792 date "2013-02-01" @default.
- W2034931792 modified "2023-09-26" @default.
- W2034931792 title "Abstract A101: Treating trastuzumab-resistant HER2+ breast cancers with a HER3-targeted nanoparticle" @default.
- W2034931792 doi "https://doi.org/10.1158/1538-7445.tim2013-a101" @default.
- W2034931792 hasPublicationYear "2013" @default.
- W2034931792 type Work @default.
- W2034931792 sameAs 2034931792 @default.
- W2034931792 citedByCount "0" @default.
- W2034931792 crossrefType "proceedings-article" @default.
- W2034931792 hasAuthorship W2034931792A5026474600 @default.
- W2034931792 hasAuthorship W2034931792A5034898797 @default.
- W2034931792 hasAuthorship W2034931792A5047542675 @default.
- W2034931792 hasAuthorship W2034931792A5062083547 @default.
- W2034931792 hasAuthorship W2034931792A5077883471 @default.
- W2034931792 hasConcept C121608353 @default.
- W2034931792 hasConcept C126322002 @default.
- W2034931792 hasConcept C2777329042 @default.
- W2034931792 hasConcept C2779786085 @default.
- W2034931792 hasConcept C2781230642 @default.
- W2034931792 hasConcept C502942594 @default.
- W2034931792 hasConcept C530470458 @default.
- W2034931792 hasConcept C71924100 @default.
- W2034931792 hasConcept C96232424 @default.
- W2034931792 hasConceptScore W2034931792C121608353 @default.
- W2034931792 hasConceptScore W2034931792C126322002 @default.
- W2034931792 hasConceptScore W2034931792C2777329042 @default.
- W2034931792 hasConceptScore W2034931792C2779786085 @default.
- W2034931792 hasConceptScore W2034931792C2781230642 @default.
- W2034931792 hasConceptScore W2034931792C502942594 @default.
- W2034931792 hasConceptScore W2034931792C530470458 @default.
- W2034931792 hasConceptScore W2034931792C71924100 @default.
- W2034931792 hasConceptScore W2034931792C96232424 @default.
- W2034931792 hasLocation W20349317921 @default.
- W2034931792 hasOpenAccess W2034931792 @default.
- W2034931792 hasPrimaryLocation W20349317921 @default.
- W2034931792 hasRelatedWork W1544749943 @default.
- W2034931792 hasRelatedWork W1977927398 @default.
- W2034931792 hasRelatedWork W1982566392 @default.
- W2034931792 hasRelatedWork W1989116686 @default.
- W2034931792 hasRelatedWork W1997056190 @default.
- W2034931792 hasRelatedWork W2009763382 @default.
- W2034931792 hasRelatedWork W2071865773 @default.
- W2034931792 hasRelatedWork W2080550759 @default.
- W2034931792 hasRelatedWork W2083748531 @default.
- W2034931792 hasRelatedWork W2090237134 @default.
- W2034931792 hasRelatedWork W2103746415 @default.
- W2034931792 hasRelatedWork W2109284739 @default.
- W2034931792 hasRelatedWork W2323684834 @default.
- W2034931792 hasRelatedWork W2396317271 @default.
- W2034931792 hasRelatedWork W2565658677 @default.
- W2034931792 hasRelatedWork W2887612026 @default.
- W2034931792 hasRelatedWork W2924993030 @default.
- W2034931792 hasRelatedWork W2955157624 @default.
- W2034931792 hasRelatedWork W296679653 @default.
- W2034931792 hasRelatedWork W2188698814 @default.
- W2034931792 isParatext "false" @default.
- W2034931792 isRetracted "false" @default.
- W2034931792 magId "2034931792" @default.
- W2034931792 workType "article" @default.